AgeX Therapeutics Inc

ASE:AGE   3:59:54 PM EDT
0.80
+0.07 (+9.59%)
Earnings Announcements

AgeX Raises Doubt Regarding Ability To Continue As Going Concern

Published: 05/13/2022 20:18 GMT
AgeX Therapeutics Inc (AGE) - Agex Therapeutics Reports First Quarter 2022 Financial Results.
Substantial Doubt Regarding Ability of Agex to Continue As a Going Concern.
Qtrly Net Loss per Common Share, Basic and Diluted From Continuing Operations $(0.07).